We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Piper Jaffray Companies | NYSE:PJC | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 79.62 | 0 | 00:00:00 |
|
☑
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
30-0168701
|
||
(State or Other Jurisdiction of Incorporation or Organization)
|
|
(IRS Employer Identification No.)
|
||
800 Nicollet Mall, Suite 900
|
|
|
||
Minneapolis
|
,
|
Minnesota
|
|
55402
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
||
(612)
|
303-6000
|
|
||
(Registrant's Telephone Number, Including Area Code)
|
Securities registered pursuant to Section 12(b) of the Act:
|
||
Title of Each Class
|
Trading Symbol
|
Name of Each Exchange On Which Registered
|
Common Stock, par value $0.01 per share
|
PIPR
|
The New York Stock Exchange
|
Large accelerated filer
|
☑
|
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
|
Smaller reporting company
|
☐
|
|
|
|
Emerging growth company
|
☐
|
|
PART I. FINANCIAL INFORMATION
|
|||
|
|
|
|
ITEM 1.
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
ITEM 2.
|
|
||
ITEM 3.
|
|
||
ITEM 4.
|
|
||
|
|
|
|
PART II. OTHER INFORMATION
|
|||
|
|
|
|
ITEM 1.
|
|
||
ITEM 1A.
|
|
||
ITEM 2.
|
|
||
ITEM 6.
|
|
||
|
|
|
March 31,
|
|
December 31,
|
||||
|
2020
|
|
2019
|
||||
(Amounts in thousands, except share data)
|
(Unaudited)
|
|
|
||||
Assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
128,582
|
|
|
$
|
250,018
|
|
Receivables from brokers, dealers and clearing organizations
|
16,962
|
|
|
283,108
|
|
||
|
|
|
|
||||
Financial instruments and other inventory positions owned
|
241,395
|
|
|
434,088
|
|
||
Financial instruments and other inventory positions owned and pledged as collateral
|
369,948
|
|
|
205,674
|
|
||
Total financial instruments and other inventory positions owned
|
611,343
|
|
|
639,762
|
|
||
|
|
|
|
||||
Fixed assets (net of accumulated depreciation and amortization of $68,397 and $65,991, respectively)
|
36,315
|
|
|
29,850
|
|
||
Goodwill
|
181,808
|
|
|
87,649
|
|
||
Intangible assets (net of accumulated amortization of $50,742 and $40,864, respectively)
|
164,408
|
|
|
16,686
|
|
||
Investments
|
141,542
|
|
|
158,141
|
|
||
Net deferred income tax assets
|
79,360
|
|
|
68,035
|
|
||
Right-of-use lease asset
|
74,847
|
|
|
40,030
|
|
||
Other assets
|
82,713
|
|
|
55,440
|
|
||
Total assets
|
$
|
1,517,880
|
|
|
$
|
1,628,719
|
|
|
|
|
|
||||
Liabilities and Shareholders' Equity
|
|
|
|
||||
Short-term financing
|
$
|
99,980
|
|
|
$
|
49,978
|
|
Senior notes
|
175,000
|
|
|
175,000
|
|
||
Payables to brokers, dealers and clearing organizations
|
16,201
|
|
|
7,514
|
|
||
Financial instruments and other inventory positions sold, but not yet purchased
|
147,118
|
|
|
185,425
|
|
||
Accrued compensation
|
126,990
|
|
|
300,527
|
|
||
Accrued lease liability
|
91,276
|
|
|
57,169
|
|
||
Other liabilities and accrued expenses
|
65,240
|
|
|
46,578
|
|
||
Total liabilities
|
721,805
|
|
|
822,191
|
|
||
|
|
|
|
||||
Shareholders' equity:
|
|
|
|
||||
Common stock, $0.01 par value:
|
|
|
|
||||
Shares authorized: 100,000,000 at March 31, 2020 and December 31, 2019;
|
|
|
|
||||
Shares issued: 19,526,398 at March 31, 2020 and 19,526,533 at December 31, 2019;
|
|
|
|
||||
Shares outstanding: 13,783,930 at March 31, 2020 and 13,717,315 at December 31, 2019
|
195
|
|
|
195
|
|
||
Additional paid-in capital
|
790,478
|
|
|
757,669
|
|
||
Retained earnings
|
227,876
|
|
|
258,669
|
|
||
Less common stock held in treasury, at cost: 5,742,468 shares at March 31, 2020 and 5,809,218 shares at December 31, 2019
|
(287,446
|
)
|
|
(284,378
|
)
|
||
Accumulated other comprehensive loss
|
(1,544
|
)
|
|
(872
|
)
|
||
Total common shareholders' equity
|
729,559
|
|
|
731,283
|
|
||
|
|
|
|
||||
Noncontrolling interests
|
66,516
|
|
|
75,245
|
|
||
Total shareholders' equity
|
796,075
|
|
|
806,528
|
|
||
|
|
|
|
||||
Total liabilities and shareholders' equity
|
$
|
1,517,880
|
|
|
$
|
1,628,719
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in thousands, except per share data)
|
2020
|
|
2019
|
||||
|
|
|
|
||||
Revenues:
|
|
|
|
||||
Investment banking
|
$
|
158,998
|
|
|
$
|
141,061
|
|
Institutional brokerage
|
89,143
|
|
|
34,965
|
|
||
Interest income
|
6,065
|
|
|
7,567
|
|
||
Investment income/(loss)
|
(13,826
|
)
|
|
1,592
|
|
||
|
|
|
|
||||
Total revenues
|
240,380
|
|
|
185,185
|
|
||
|
|
|
|
||||
Interest expense
|
4,212
|
|
|
2,643
|
|
||
|
|
|
|
||||
Net revenues
|
236,168
|
|
|
182,542
|
|
||
|
|
|
|
||||
Non-interest expenses:
|
|
|
|
||||
Compensation and benefits
|
188,124
|
|
|
117,127
|
|
||
Outside services
|
8,439
|
|
|
8,571
|
|
||
Occupancy and equipment
|
12,238
|
|
|
8,349
|
|
||
Communications
|
11,634
|
|
|
7,865
|
|
||
Marketing and business development
|
10,039
|
|
|
6,738
|
|
||
Deal-related expenses
|
4,940
|
|
|
4,728
|
|
||
Trade execution and clearance
|
7,151
|
|
|
1,806
|
|
||
Restructuring and integration costs
|
1,902
|
|
|
—
|
|
||
Intangible asset amortization
|
9,878
|
|
|
753
|
|
||
Other operating expenses
|
15,852
|
|
|
3,468
|
|
||
|
|
|
|
||||
Total non-interest expenses
|
270,197
|
|
|
159,405
|
|
||
|
|
|
|
||||
Income/(loss) from continuing operations before income tax expense/(benefit)
|
(34,029
|
)
|
|
23,137
|
|
||
|
|
|
|
||||
Income tax expense/(benefit)
|
(11,774
|
)
|
|
4,192
|
|
||
|
|
|
|
||||
Income/(loss) from continuing operations
|
(22,255
|
)
|
|
18,945
|
|
||
|
|
|
|
||||
Discontinued operations:
|
|
|
|
||||
Loss from discontinued operations, net of tax
|
—
|
|
|
(139
|
)
|
||
|
|
|
|
||||
Net income/(loss)
|
(22,255
|
)
|
|
18,806
|
|
||
|
|
|
|
||||
Net loss applicable to noncontrolling interests
|
(7,528
|
)
|
|
(616
|
)
|
||
|
|
|
|
||||
Net income/(loss) applicable to Piper Sandler Companies
|
$
|
(14,727
|
)
|
|
$
|
19,422
|
|
|
|
|
|
||||
Net income/(loss) applicable to Piper Sandler Companies' common shareholders
|
$
|
(14,727
|
)
|
|
$
|
17,835
|
|
|
|
|
|
||||
Continued on next page
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in thousands, except per share data)
|
2020
|
|
2019
|
||||
|
|
|
|
||||
Amounts applicable to Piper Sandler Companies
|
|
|
|
||||
Net income/(loss) from continuing operations
|
$
|
(14,727
|
)
|
|
$
|
19,561
|
|
Net loss from discontinued operations
|
—
|
|
|
(139
|
)
|
||
Net income/(loss) applicable to Piper Sandler Companies
|
$
|
(14,727
|
)
|
|
$
|
19,422
|
|
|
|
|
|
||||
Earnings/(loss) per basic common share
|
|
|
|
||||
Income/(loss) from continuing operations
|
$
|
(1.07
|
)
|
|
$
|
1.36
|
|
Loss from discontinued operations
|
—
|
|
|
(0.01
|
)
|
||
Earnings/(loss) per basic common share
|
$
|
(1.07
|
)
|
|
$
|
1.35
|
|
|
|
|
|
||||
Earnings/(loss) per diluted common share
|
|
|
|
||||
Income/(loss) from continuing operations
|
$
|
(1.07
|
)
|
|
$
|
1.33
|
|
Loss from discontinued operations
|
—
|
|
|
(0.01
|
)
|
||
Earnings/(loss) per diluted common share
|
$
|
(1.07
|
)
|
|
$
|
1.32
|
|
|
|
|
|
||||
Dividends declared per common share
|
$
|
1.13
|
|
|
$
|
1.39
|
|
|
|
|
|
||||
Weighted average common shares outstanding
|
|
|
|
||||
Basic
|
13,796
|
|
|
13,204
|
|
||
Diluted
|
14,411
|
|
|
13,530
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Net income/(loss)
|
$
|
(22,255
|
)
|
|
$
|
18,806
|
|
|
|
|
|
||||
Other comprehensive income/(loss), net of tax:
|
|
|
|
||||
Foreign currency translation adjustment
|
(672
|
)
|
|
215
|
|
||
|
|
|
|
||||
Comprehensive income/(loss)
|
(22,927
|
)
|
|
19,021
|
|
||
|
|
|
|
||||
Comprehensive loss applicable to noncontrolling interests
|
(7,528
|
)
|
|
(616
|
)
|
||
|
|
|
|
||||
Comprehensive income/(loss) applicable to Piper Sandler Companies
|
$
|
(15,399
|
)
|
|
$
|
19,637
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
Total
|
|
|
|
|
|||||||||||||||||
|
|
Common
|
|
|
|
Additional
|
|
|
|
|
|
Other
|
|
Common
|
|
|
|
Total
|
|||||||||||||||||
(Amounts in thousands,
|
|
Shares
|
|
Common
|
|
Paid-In
|
|
Retained
|
|
Treasury
|
|
Comprehensive
|
|
Shareholders'
|
|
Noncontrolling
|
|
Shareholders'
|
|||||||||||||||||
except share amounts)
|
|
Outstanding
|
|
Stock
|
|
Capital
|
|
Earnings
|
|
Stock
|
|
Loss
|
|
Equity
|
|
Interests
|
|
Equity
|
|||||||||||||||||
Balance at December 31, 2019
|
|
13,717,315
|
|
|
$
|
195
|
|
|
$
|
757,669
|
|
|
$
|
258,669
|
|
|
$
|
(284,378
|
)
|
|
$
|
(872
|
)
|
|
$
|
731,283
|
|
|
$
|
75,245
|
|
|
$
|
806,528
|
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,727
|
)
|
|
—
|
|
|
—
|
|
|
(14,727
|
)
|
|
(7,528
|
)
|
|
(22,255
|
)
|
||||||||
Dividends
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,066
|
)
|
|
—
|
|
|
—
|
|
|
(16,066
|
)
|
|
—
|
|
|
(16,066
|
)
|
||||||||
Amortization/issuance of restricted stock (1)
|
|
—
|
|
|
—
|
|
|
44,195
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
44,195
|
|
|
—
|
|
|
44,195
|
|
||||||||
Repurchase of common stock through share repurchase program
|
|
(128,865
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,225
|
)
|
|
—
|
|
|
(9,225
|
)
|
|
—
|
|
|
(9,225
|
)
|
||||||||
Issuance of treasury shares for restricted stock vestings
|
|
254,111
|
|
|
—
|
|
|
(12,551
|
)
|
|
—
|
|
|
12,551
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Issuance of treasury shares for deal consideration
|
|
34,205
|
|
|
—
|
|
|
1,049
|
|
|
—
|
|
|
1,674
|
|
|
—
|
|
|
2,723
|
|
|
—
|
|
|
2,723
|
|
||||||||
Repurchase of common stock from employees
|
|
(94,615
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,068
|
)
|
|
—
|
|
|
(8,068
|
)
|
|
—
|
|
|
(8,068
|
)
|
||||||||
Shares reserved/issued for director compensation
|
|
1,779
|
|
|
—
|
|
|
116
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
116
|
|
|
—
|
|
|
116
|
|
||||||||
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(672
|
)
|
|
(672
|
)
|
|
—
|
|
|
(672
|
)
|
||||||||
Fund capital distributions, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,201
|
)
|
|
(1,201
|
)
|
||||||||
Balance at March 31, 2020
|
|
13,783,930
|
|
|
$
|
195
|
|
|
$
|
790,478
|
|
|
$
|
227,876
|
|
|
$
|
(287,446
|
)
|
|
$
|
(1,544
|
)
|
|
$
|
729,559
|
|
|
$
|
66,516
|
|
|
$
|
796,075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at December 31, 2018
|
|
12,995,397
|
|
|
$
|
195
|
|
|
$
|
796,363
|
|
|
$
|
182,552
|
|
|
$
|
(300,268
|
)
|
|
$
|
(1,398
|
)
|
|
$
|
677,444
|
|
|
$
|
52,972
|
|
|
$
|
730,416
|
|
Net income/(loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,422
|
|
|
—
|
|
|
—
|
|
|
19,422
|
|
|
(616
|
)
|
|
18,806
|
|
||||||||
Dividends
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(19,947
|
)
|
|
—
|
|
|
—
|
|
|
(19,947
|
)
|
|
—
|
|
|
(19,947
|
)
|
||||||||
Amortization/issuance of restricted stock
|
|
—
|
|
|
—
|
|
|
23,826
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
23,826
|
|
|
—
|
|
|
23,826
|
|
||||||||
Repurchase of common stock through share repurchase program
|
|
(501
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(32
|
)
|
|
—
|
|
|
(32
|
)
|
|
—
|
|
|
(32
|
)
|
||||||||
Issuance of treasury shares for restricted stock vestings
|
|
1,035,360
|
|
|
—
|
|
|
(48,092
|
)
|
|
—
|
|
|
48,092
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Repurchase of common stock from employees
|
|
(563,284
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(39,695
|
)
|
|
—
|
|
|
(39,695
|
)
|
|
—
|
|
|
(39,695
|
)
|
||||||||
Shares reserved/issued for director compensation
|
|
1,263
|
|
|
—
|
|
|
87
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
87
|
|
|
—
|
|
|
87
|
|
||||||||
Other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
215
|
|
|
215
|
|
|
—
|
|
|
215
|
|
||||||||
Fund capital distributions, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
(5
|
)
|
||||||||
Balance at March 31, 2019
|
|
13,468,235
|
|
|
$
|
195
|
|
|
$
|
772,184
|
|
|
$
|
182,027
|
|
|
$
|
(291,903
|
)
|
|
$
|
(1,183
|
)
|
|
$
|
661,320
|
|
|
$
|
52,351
|
|
|
$
|
713,671
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Operating Activities:
|
|
|
|
||||
Net income/(loss)
|
$
|
(22,255
|
)
|
|
$
|
18,806
|
|
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization of fixed assets
|
2,632
|
|
|
2,392
|
|
||
Deferred income taxes
|
(11,325
|
)
|
|
13,855
|
|
||
Stock-based compensation
|
21,795
|
|
|
4,350
|
|
||
Amortization of intangible assets
|
9,878
|
|
|
2,112
|
|
||
Amortization of forgivable loans
|
1,068
|
|
|
1,503
|
|
||
Decrease/(increase) in operating assets:
|
|
|
|
||||
Receivables from brokers, dealers and clearing organizations
|
458,821
|
|
|
188,268
|
|
||
Net financial instruments and other inventory positions owned
|
(9,888
|
)
|
|
(17,359
|
)
|
||
Investments
|
17,284
|
|
|
(62
|
)
|
||
Other assets
|
(13,937
|
)
|
|
(3,936
|
)
|
||
Increase/(decrease) in operating liabilities:
|
|
|
|
||||
Payables to brokers, dealers and clearing organizations
|
8,687
|
|
|
(2,385
|
)
|
||
Accrued compensation
|
(222,256
|
)
|
|
(163,104
|
)
|
||
Other liabilities and accrued expenses
|
(2,912
|
)
|
|
(8,318
|
)
|
||
Increase in assets held for sale
|
—
|
|
|
(383
|
)
|
||
Decrease in liabilities held for sale
|
—
|
|
|
(7,218
|
)
|
||
|
|
|
|
||||
Net cash provided by operating activities
|
237,592
|
|
|
28,521
|
|
||
|
|
|
|
||||
Investing Activities:
|
|
|
|
||||
Business acquisitions, net of cash acquired
|
(371,369
|
)
|
|
—
|
|
||
Purchases of fixed assets, net
|
(2,359
|
)
|
|
(1,421
|
)
|
||
|
|
|
|
||||
Net cash used in investing activities
|
(373,728
|
)
|
|
(1,421
|
)
|
||
|
|
|
|
||||
Financing Activities:
|
|
|
|
||||
Increase in short-term financing
|
50,002
|
|
|
3
|
|
||
Payment of cash dividend
|
(16,066
|
)
|
|
(19,947
|
)
|
||
Decrease in noncontrolling interests
|
(1,201
|
)
|
|
(5
|
)
|
||
Repurchase of common stock
|
(17,293
|
)
|
|
(39,727
|
)
|
||
|
|
|
|
||||
Net cash provided by/(used in) financing activities
|
15,442
|
|
|
(59,676
|
)
|
||
|
|
|
|
||||
Currency adjustment:
|
|
|
|
||||
Effect of exchange rate changes on cash
|
(742
|
)
|
|
457
|
|
||
|
|
|
|
||||
Net decrease in cash and cash equivalents
|
(121,436
|
)
|
|
(32,119
|
)
|
||
|
|
|
|
||||
Cash and cash equivalents at beginning of period
|
250,018
|
|
|
50,364
|
|
||
|
|
|
|
||||
Cash and cash equivalents at end of period
|
$
|
128,582
|
|
|
$
|
18,245
|
|
|
|
|
|
||||
Supplemental disclosure of cash flow information:
|
|
|
|
||||
Cash paid during the period for:
|
|
|
|
||||
Interest
|
$
|
4,127
|
|
|
$
|
2,809
|
|
Income taxes
|
$
|
557
|
|
|
$
|
7,462
|
|
Note 1
|
|
||
Note 2
|
|
||
Note 3
|
|
||
Note 4
|
|
||
Note 5
|
|
||
Note 6
|
|
||
Note 7
|
|
||
Note 8
|
|
||
Note 9
|
|
||
Note 10
|
|
||
Note 11
|
|
||
Note 12
|
|
||
Note 13
|
|
||
Note 14
|
|
||
Note 15
|
|
||
Note 16
|
|
||
Note 17
|
|
||
Note 18
|
|
||
Note 19
|
|
||
Note 20
|
|
||
Note 21
|
|
||
Note 22
|
|
(1)
|
Represents the amount of excess tangible book value received by the Company on the date of acquisition.
|
|
Three Months Ended
|
||||
(Amounts in thousands)
|
March 31, 2019
|
||||
Net revenues
|
$
|
291,254
|
|
||
Net income from continuing operations applicable to Piper Sandler Companies
|
11,482
|
|
|
|
Three Months Ended
|
||
(Amounts in thousands)
|
|
March 31, 2019
|
||
Net revenues
|
|
$
|
9,290
|
|
|
|
|
||
Operating expenses
|
|
8,139
|
|
|
Intangible asset amortization
|
|
1,359
|
|
|
Total non-interest expenses
|
|
9,498
|
|
|
|
|
|
||
Loss from discontinued operations before income tax benefit
|
|
(208
|
)
|
|
|
|
|
||
Income tax benefit
|
|
(69
|
)
|
|
|
|
|
||
Loss from discontinued operations, net of tax
|
|
$
|
(139
|
)
|
|
March 31,
|
|
December 31,
|
||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Financial instruments and other inventory positions owned:
|
|
|
|
||||
Corporate securities:
|
|
|
|
||||
Equity securities
|
$
|
2,827
|
|
|
$
|
3,046
|
|
Convertible securities
|
117,915
|
|
|
146,406
|
|
||
Fixed income securities
|
84,651
|
|
|
28,176
|
|
||
Municipal securities:
|
|
|
|
||||
Taxable securities
|
26,260
|
|
|
22,570
|
|
||
Tax-exempt securities
|
214,817
|
|
|
222,192
|
|
||
Short-term securities
|
63,406
|
|
|
67,901
|
|
||
Mortgage-backed securities
|
13
|
|
|
13
|
|
||
U.S. government agency securities
|
68,076
|
|
|
51,773
|
|
||
U.S. government securities
|
407
|
|
|
77,303
|
|
||
Derivative contracts
|
32,971
|
|
|
20,382
|
|
||
Total financial instruments and other inventory positions owned
|
$
|
611,343
|
|
|
$
|
639,762
|
|
|
|
|
|
||||
Financial instruments and other inventory positions sold, but not yet purchased:
|
|
|
|
||||
Corporate securities:
|
|
|
|
||||
Equity securities
|
$
|
50,895
|
|
|
$
|
94,036
|
|
Fixed income securities
|
13,995
|
|
|
10,311
|
|
||
U.S. government agency securities
|
881
|
|
|
9,935
|
|
||
U.S. government securities
|
73,207
|
|
|
67,090
|
|
||
Derivative contracts
|
8,140
|
|
|
4,053
|
|
||
Total financial instruments and other inventory positions sold, but not yet purchased
|
$
|
147,118
|
|
|
$
|
185,425
|
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||||||||||||
(Amounts in thousands)
|
|
Derivative
|
|
Derivative
|
|
Notional
|
|
Derivative
|
|
Derivative
|
|
Notional
|
||||||||||||
Derivative Category
|
|
Assets (1)
|
|
Liabilities (2)
|
|
Amount
|
|
Assets (1)
|
|
Liabilities (2)
|
|
Amount
|
||||||||||||
Interest rate
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Customer matched-book
|
|
$
|
264,559
|
|
|
$
|
253,830
|
|
|
$
|
2,023,391
|
|
|
$
|
209,119
|
|
|
$
|
198,315
|
|
|
$
|
2,197,340
|
|
Trading securities
|
|
1,975
|
|
|
6,502
|
|
|
209,075
|
|
|
8
|
|
|
1,852
|
|
|
110,875
|
|
||||||
Equity options
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Trading securities
|
|
—
|
|
|
1,386
|
|
|
16,218
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
266,534
|
|
|
$
|
261,718
|
|
|
$
|
2,248,684
|
|
|
$
|
209,127
|
|
|
$
|
200,167
|
|
|
$
|
2,308,215
|
|
(1)
|
Derivative assets are included within financial instruments and other inventory positions owned on the consolidated statements of financial condition.
|
(2)
|
Derivative liabilities are included within financial instruments and other inventory positions sold, but not yet purchased on the consolidated statements of financial condition.
|
|
|
|
|
Three Months Ended
|
||||||
(Amounts in thousands)
|
|
|
|
March 31,
|
||||||
Derivative Category
|
|
Operations Category
|
|
2020
|
|
2019
|
||||
Interest rate derivative contract
|
|
Investment banking
|
|
$
|
(732
|
)
|
|
$
|
(617
|
)
|
Interest rate derivative contract
|
|
Institutional brokerage
|
|
(2,027
|
)
|
|
(249
|
)
|
||
Equity option derivative contracts
|
|
Institutional brokerage
|
|
(822
|
)
|
|
—
|
|
||
|
|
|
|
$
|
(3,581
|
)
|
|
$
|
(866
|
)
|
|
Valuation
|
|
|
|
|
|
Weighted
|
|
Technique
|
|
Unobservable Input
|
|
Range
|
|
Average (1)
|
Assets
|
|
|
|
|
|
|
|
Financial instruments and other inventory positions owned:
|
|
|
|
|
|
|
|
Derivative contracts:
|
|
|
|
|
|
|
|
Interest rate locks
|
Discounted cash flow
|
|
Premium over the MMD curve in basis points ("bps") (2)
|
|
5 - 35 bps
|
|
15.4 bps
|
Investments at fair value:
|
|
|
|
|
|
|
|
Equity securities in private companies
|
Market approach
|
|
Revenue multiple (2)
|
|
3 - 5 times
|
|
3.8 times
|
|
|
|
EBITDA multiple (2)
|
|
10 - 20 times
|
|
16.1 times
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
Financial instruments and other inventory positions sold, but not yet purchased:
|
|
|
|
|
|
|
|
Derivative contracts:
|
|
|
|
|
|
|
|
Interest rate locks
|
Discounted cash flow
|
|
Premium over the MMD curve in bps (3)
|
|
8 - 62 bps
|
|
51.7 bps
|
(1)
|
Unobservable inputs were weighted by the relative fair value of the financial instruments.
|
(2)
|
Significant increase/(decrease) in the unobservable input in isolation would have resulted in a significantly higher/(lower) fair value measurement.
|
(3)
|
Significant increase/(decrease) in the unobservable input in isolation would have resulted in a significantly lower/(higher) fair value measurement.
|
|
|
|
|
|
|
|
Counterparty
|
|
|
||||||||||
|
|
|
|
|
|
|
and Cash
|
|
|
||||||||||
|
|
|
|
|
|
|
Collateral
|
|
|
||||||||||
(Amounts in thousands)
|
Level I
|
|
Level II
|
|
Level III
|
|
Netting (1)
|
|
Total
|
||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial instruments and other inventory positions owned:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Equity securities
|
$
|
165
|
|
|
$
|
2,662
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,827
|
|
Convertible securities
|
—
|
|
|
117,915
|
|
|
—
|
|
|
—
|
|
|
117,915
|
|
|||||
Fixed income securities
|
—
|
|
|
84,651
|
|
|
—
|
|
|
—
|
|
|
84,651
|
|
|||||
Municipal securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Taxable securities
|
—
|
|
|
26,260
|
|
|
—
|
|
|
—
|
|
|
26,260
|
|
|||||
Tax-exempt securities
|
—
|
|
|
214,817
|
|
|
—
|
|
|
—
|
|
|
214,817
|
|
|||||
Short-term securities
|
—
|
|
|
63,406
|
|
|
—
|
|
|
—
|
|
|
63,406
|
|
|||||
Mortgage-backed securities
|
—
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|||||
U.S. government agency securities
|
—
|
|
|
68,076
|
|
|
—
|
|
|
—
|
|
|
68,076
|
|
|||||
U.S. government securities
|
407
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
407
|
|
|||||
Derivative contracts
|
—
|
|
|
264,559
|
|
|
1,975
|
|
|
(233,563
|
)
|
|
32,971
|
|
|||||
Total financial instruments and other inventory positions owned
|
572
|
|
|
842,346
|
|
|
1,988
|
|
|
(233,563
|
)
|
|
611,343
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash equivalents
|
4,916
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,916
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Investments at fair value
|
13,838
|
|
|
—
|
|
|
120,730
|
|
(2)
|
—
|
|
|
134,568
|
|
|||||
Total assets
|
$
|
19,326
|
|
|
$
|
842,346
|
|
|
$
|
122,718
|
|
|
$
|
(233,563
|
)
|
|
$
|
750,827
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial instruments and other inventory positions sold, but not yet purchased:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Equity securities
|
$
|
50,872
|
|
|
$
|
23
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
50,895
|
|
Fixed income securities
|
—
|
|
|
13,995
|
|
|
—
|
|
|
—
|
|
|
13,995
|
|
|||||
U.S. government agency securities
|
—
|
|
|
881
|
|
|
—
|
|
|
—
|
|
|
881
|
|
|||||
U.S. government securities
|
73,207
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
73,207
|
|
|||||
Derivative contracts
|
1,386
|
|
|
254,775
|
|
|
5,557
|
|
|
(253,578
|
)
|
|
8,140
|
|
|||||
Total financial instruments and other inventory positions sold, but not yet purchased
|
$
|
125,465
|
|
|
$
|
269,674
|
|
|
$
|
5,557
|
|
|
$
|
(253,578
|
)
|
|
$
|
147,118
|
|
(1)
|
Represents cash collateral and the impact of netting on a counterparty basis. The Company had no securities posted as collateral to its counterparties.
|
(2)
|
Includes noncontrolling interests of $66.5 million primarily attributable to unrelated third party ownership in consolidated merchant banking funds.
|
|
|
|
|
|
|
|
Counterparty
|
|
|
||||||||||
|
|
|
|
|
|
|
and Cash
|
|
|
||||||||||
|
|
|
|
|
|
|
Collateral
|
|
|
||||||||||
(Amounts in thousands)
|
Level I
|
|
Level II
|
|
Level III
|
|
Netting (1)
|
|
Total
|
||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial instruments and other inventory positions owned:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Equity securities
|
$
|
469
|
|
|
$
|
2,577
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,046
|
|
Convertible securities
|
—
|
|
|
146,406
|
|
|
—
|
|
|
—
|
|
|
146,406
|
|
|||||
Fixed income securities
|
—
|
|
|
28,176
|
|
|
—
|
|
|
—
|
|
|
28,176
|
|
|||||
Municipal securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Taxable securities
|
—
|
|
|
22,570
|
|
|
—
|
|
|
—
|
|
|
22,570
|
|
|||||
Tax-exempt securities
|
—
|
|
|
222,192
|
|
|
—
|
|
|
—
|
|
|
222,192
|
|
|||||
Short-term securities
|
—
|
|
|
67,901
|
|
|
—
|
|
|
—
|
|
|
67,901
|
|
|||||
Mortgage-backed securities
|
—
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|||||
U.S. government agency securities
|
—
|
|
|
51,773
|
|
|
—
|
|
|
—
|
|
|
51,773
|
|
|||||
U.S. government securities
|
77,303
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
77,303
|
|
|||||
Derivative contracts
|
—
|
|
|
209,119
|
|
|
8
|
|
|
(188,745
|
)
|
|
20,382
|
|
|||||
Total financial instruments and other inventory positions owned
|
77,772
|
|
|
750,714
|
|
|
21
|
|
|
(188,745
|
)
|
|
639,762
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash equivalents
|
226,744
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
226,744
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Investments at fair value
|
17,658
|
|
|
—
|
|
|
132,329
|
|
(2)
|
—
|
|
|
149,987
|
|
|||||
Total assets
|
$
|
322,174
|
|
|
$
|
750,714
|
|
|
$
|
132,350
|
|
|
$
|
(188,745
|
)
|
|
$
|
1,016,493
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
Financial instruments and other inventory positions sold, but not yet purchased:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Equity securities
|
$
|
88,794
|
|
|
$
|
5,242
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
94,036
|
|
Fixed income securities
|
—
|
|
|
10,311
|
|
|
—
|
|
|
—
|
|
|
10,311
|
|
|||||
U.S. government agency securities
|
—
|
|
|
9,935
|
|
|
—
|
|
|
—
|
|
|
9,935
|
|
|||||
U.S. government securities
|
67,090
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
67,090
|
|
|||||
Derivative contracts
|
—
|
|
|
198,604
|
|
|
1,563
|
|
|
(196,114
|
)
|
|
4,053
|
|
|||||
Total financial instruments and other inventory positions sold, but not yet purchased
|
$
|
155,884
|
|
|
$
|
224,092
|
|
|
$
|
1,563
|
|
|
$
|
(196,114
|
)
|
|
$
|
185,425
|
|
(1)
|
Represents cash collateral and the impact of netting on a counterparty basis. The Company had no securities posted as collateral to its counterparties.
|
(2)
|
Includes noncontrolling interests of $75.2 million primarily attributable to unrelated third party ownership in consolidated merchant banking funds.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains/
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(losses) for assets/
|
||||||||||||||||
|
Balance at
|
|
|
|
|
|
|
|
Realized
|
|
Unrealized
|
|
Balance at
|
|
liabilities held at
|
||||||||||||||||
|
December 31,
|
|
|
|
|
|
Transfers
|
|
gains/
|
|
gains/
|
|
March 31,
|
|
March 31,
|
||||||||||||||||
(Amounts in thousands)
|
2019
|
|
Purchases
|
|
Sales
|
|
out
|
|
(losses)
|
|
(losses)
|
|
2020
|
|
2020
|
||||||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Financial instruments and other inventory positions owned:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Mortgage-backed securities
|
$
|
13
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
13
|
|
|
$
|
—
|
|
Derivative contracts
|
8
|
|
|
295
|
|
|
—
|
|
|
—
|
|
|
(295
|
)
|
|
1,967
|
|
|
1,975
|
|
|
1,975
|
|
||||||||
Total financial instruments and other inventory positions owned
|
21
|
|
|
295
|
|
|
—
|
|
|
—
|
|
|
(295
|
)
|
|
1,967
|
|
|
1,988
|
|
|
1,975
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Investments at fair value
|
132,329
|
|
|
283
|
|
|
(165
|
)
|
|
(130
|
)
|
|
(227
|
)
|
|
(11,360
|
)
|
|
120,730
|
|
|
(11,585
|
)
|
||||||||
Total assets
|
$
|
132,350
|
|
|
$
|
578
|
|
|
$
|
(165
|
)
|
|
$
|
(130
|
)
|
|
$
|
(522
|
)
|
|
$
|
(9,393
|
)
|
|
$
|
122,718
|
|
|
$
|
(9,610
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Financial instruments and other inventory positions sold, but not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Derivative contracts
|
$
|
1,563
|
|
|
$
|
(3,141
|
)
|
|
$
|
351
|
|
|
$
|
—
|
|
|
$
|
2,790
|
|
|
$
|
3,994
|
|
|
$
|
5,557
|
|
|
$
|
5,547
|
|
Total financial instruments and other inventory positions sold, but not yet purchased
|
$
|
1,563
|
|
|
$
|
(3,141
|
)
|
|
$
|
351
|
|
|
$
|
—
|
|
|
$
|
2,790
|
|
|
$
|
3,994
|
|
|
$
|
5,557
|
|
|
$
|
5,547
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains/
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(losses) for assets/
|
||||||||||||||||
|
Balance at
|
|
|
|
|
|
|
|
Realized
|
|
Unrealized
|
|
Balance at
|
|
liabilities held at
|
||||||||||||||||
|
December 31,
|
|
|
|
|
|
Transfers
|
|
gains/
|
|
gains/
|
|
March 31,
|
|
March 31,
|
||||||||||||||||
(Amounts in thousands)
|
2018
|
|
Purchases
|
|
Sales
|
|
out
|
|
(losses)
|
|
(losses)
|
|
2019
|
|
2019
|
||||||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Financial instruments and other inventory positions owned:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Mortgage-backed securities
|
$
|
15
|
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
|
$
|
—
|
|
|
$
|
(27
|
)
|
|
$
|
28
|
|
|
$
|
14
|
|
|
$
|
—
|
|
Derivative contracts
|
229
|
|
|
—
|
|
|
(336
|
)
|
|
—
|
|
|
336
|
|
|
(229
|
)
|
|
—
|
|
|
—
|
|
||||||||
Total financial instruments and other inventory positions owned
|
244
|
|
|
—
|
|
|
(338
|
)
|
|
—
|
|
|
309
|
|
|
(201
|
)
|
|
14
|
|
|
—
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Investments at fair value
|
107,792
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
86
|
|
|
107,878
|
|
|
86
|
|
||||||||
Total assets
|
$
|
108,036
|
|
|
$
|
—
|
|
|
$
|
(338
|
)
|
|
$
|
—
|
|
|
$
|
309
|
|
|
$
|
(115
|
)
|
|
$
|
107,892
|
|
|
$
|
86
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Financial instruments and other inventory positions sold, but not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Derivative contracts
|
$
|
4,202
|
|
|
$
|
(5,603
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,603
|
|
|
$
|
20
|
|
|
$
|
4,222
|
|
|
$
|
4,222
|
|
Total financial instruments and other inventory positions sold, but not yet purchased
|
$
|
4,202
|
|
|
$
|
(5,603
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,603
|
|
|
$
|
20
|
|
|
$
|
4,222
|
|
|
$
|
4,222
|
|
|
|
Alternative Asset
|
||
(Amounts in thousands)
|
|
Management Funds
|
||
Assets
|
|
|
||
Investments
|
|
$
|
118,508
|
|
Other assets
|
|
647
|
|
|
Total assets
|
|
$
|
119,155
|
|
|
|
|
||
Liabilities
|
|
|
||
Other liabilities and accrued expenses
|
|
$
|
2,540
|
|
Total liabilities
|
|
$
|
2,540
|
|
|
March 31,
|
|
December 31,
|
||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Receivable from clearing organizations
|
$
|
7,406
|
|
|
$
|
260,436
|
|
Receivable from brokers and dealers
|
5,967
|
|
|
19,161
|
|
||
Other
|
3,589
|
|
|
3,511
|
|
||
Total receivables from brokers, dealers and clearing organizations
|
$
|
16,962
|
|
|
$
|
283,108
|
|
|
March 31,
|
|
December 31,
|
||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Payable to brokers and dealers
|
$
|
15,469
|
|
|
$
|
7,514
|
|
Payable to clearing organizations
|
732
|
|
|
—
|
|
||
Total payables to brokers, dealers and clearing organizations
|
$
|
16,201
|
|
|
$
|
7,514
|
|
|
March 31,
|
|
December 31,
|
||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Investments at fair value
|
$
|
134,568
|
|
|
$
|
149,987
|
|
Investments at cost
|
611
|
|
|
1,084
|
|
||
Investments accounted for under the equity method
|
6,363
|
|
|
7,070
|
|
||
Total investments
|
141,542
|
|
|
158,141
|
|
||
|
|
|
|
||||
Less investments attributable to noncontrolling interests (1)
|
(66,516
|
)
|
|
(75,245
|
)
|
||
|
$
|
75,026
|
|
|
$
|
82,896
|
|
(1)
|
Noncontrolling interests are primarily attributable to unrelated third party ownership in consolidated merchant banking funds.
|
|
March 31,
|
|
December 31,
|
||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Fee receivables
|
$
|
30,975
|
|
|
$
|
18,574
|
|
Accrued interest receivables
|
3,824
|
|
|
2,977
|
|
||
Income tax receivables
|
5,616
|
|
|
2,658
|
|
||
Forgivable loans, net
|
4,143
|
|
|
5,227
|
|
||
Prepaid expenses
|
12,349
|
|
|
10,687
|
|
||
Other
|
25,806
|
|
|
15,317
|
|
||
Total other assets
|
$
|
82,713
|
|
|
$
|
55,440
|
|
(Amounts in thousands)
|
|
||
Goodwill
|
|
||
Balance at December 31, 2019
|
$
|
87,649
|
|
Goodwill acquired
|
94,159
|
|
|
Balance at March 31, 2020
|
$
|
181,808
|
|
|
|
||
Intangible assets
|
|
||
Balance at December 31, 2019
|
$
|
16,686
|
|
Intangible assets acquired
|
157,600
|
|
|
Amortization of intangible assets
|
(9,878
|
)
|
|
Balance at March 31, 2020
|
$
|
164,408
|
|
(Amounts in thousands)
|
|
||
Remainder of 2020
|
$
|
29,634
|
|
2021
|
15,042
|
|
|
2022
|
9,325
|
|
|
2023
|
7,427
|
|
|
2024
|
6,280
|
|
|
Thereafter
|
11,300
|
|
|
Total
|
$
|
79,008
|
|
|
Outstanding Balance
|
|
Weighted Average Interest Rate
|
||||||||||
|
March 31,
|
|
December 31,
|
|
March 31,
|
|
December 31,
|
||||||
(Dollars in thousands)
|
2020
|
|
2019
|
|
2020
|
|
2019
|
||||||
Commercial paper
|
$
|
49,980
|
|
|
$
|
49,978
|
|
|
2.38
|
%
|
|
2.69
|
%
|
Revolving credit facility
|
50,000
|
|
|
—
|
|
|
2.91
|
%
|
|
—
|
%
|
||
Total short-term financing
|
$
|
99,980
|
|
|
$
|
49,978
|
|
|
|
|
|
(Amounts in thousands)
|
|
||
Remainder of 2020
|
$
|
17,686
|
|
2021
|
18,723
|
|
|
2022
|
17,361
|
|
|
2023
|
14,166
|
|
|
2024
|
12,262
|
|
|
Thereafter
|
25,660
|
|
|
Total
|
$
|
105,858
|
|
|
Three Months Ended
|
||
(Amounts in thousands)
|
March 31, 2020
|
||
Severance, benefits and outplacement costs
|
$
|
878
|
|
Contract termination costs
|
173
|
|
|
Total restructuring costs
|
1,051
|
|
|
|
|
||
Integration costs
|
851
|
|
|
|
|
||
Total restructuring and integration costs
|
$
|
1,902
|
|
(1)
|
The Company issued restricted stock with service conditions as part of deal consideration for the acquisition of Sandler O'Neill. See Note 3 for further discussion.
|
|
|
Probability of Achieving
|
Grant Year
|
|
Performance Condition
|
2020
|
|
75%
|
2019
|
|
62%
|
2018
|
|
50%
|
|
|
Risk-free
|
|
Expected Stock
|
Grant Year
|
|
Interest Rate
|
|
Price Volatility
|
2020
|
|
1.40%
|
|
27.3%
|
2019
|
|
2.50%
|
|
31.9%
|
2018
|
|
2.40%
|
|
34.8%
|
2017
|
|
1.62%
|
|
35.9%
|
|
|
Risk-free
|
|
Expected Stock
|
Grant Year
|
|
Interest Rate
|
|
Price Volatility
|
2016
|
|
0.98%
|
|
34.9%
|
Risk-free interest rate
|
2.82
|
%
|
|
Dividend yield
|
3.22
|
%
|
|
Expected stock price volatility
|
37.20
|
%
|
|
Expected life of options (in years)
|
7.0
|
|
|
Fair value of options granted (per share)
|
$
|
24.49
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in millions)
|
2020
|
|
2019
|
||||
Stock-based compensation expense
|
$
|
21.7
|
|
|
$
|
4.2
|
|
Forfeitures
|
0.1
|
|
|
0.9
|
|
||
Tax benefit related to stock-based compensation expense
|
2.4
|
|
|
0.4
|
|
|
Unvested
|
|
Weighted Average
|
|||
|
Restricted Stock
|
|
Grant Date
|
|||
|
(in Shares)
|
|
Fair Value
|
|||
December 31, 2019
|
694,225
|
|
|
$
|
78.52
|
|
Granted
|
2,997,052
|
|
|
80.17
|
|
|
Vested
|
(235,856
|
)
|
|
81.98
|
|
|
Canceled
|
(8,377
|
)
|
|
76.97
|
|
|
March 31, 2020
|
3,447,044
|
|
|
$
|
79.72
|
|
|
Unvested
|
|
Weighted Average
|
|||
|
Restricted
|
|
Grant Date
|
|||
|
Stock Units
|
|
Fair Value
|
|||
December 31, 2019
|
114,315
|
|
|
$
|
85.09
|
|
Granted
|
56,066
|
|
|
86.01
|
|
|
Vested
|
(18,255
|
)
|
|
84.10
|
|
|
Canceled
|
(6,078
|
)
|
|
84.10
|
|
|
March 31, 2020
|
146,048
|
|
|
$
|
85.60
|
|
|
|
|
|
|
Weighted Average
|
|
|
|||||
|
|
|
Weighted
|
|
Remaining
|
|
|
|||||
|
Options
|
|
Average
|
|
Contractual Term
|
|
Aggregate
|
|||||
|
Outstanding
|
|
Exercise Price
|
|
(in Years)
|
|
Intrinsic Value
|
|||||
December 31, 2019
|
81,667
|
|
|
$
|
99.00
|
|
|
8.1
|
|
$
|
—
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
|||
Exercised
|
—
|
|
|
—
|
|
|
|
|
|
|||
Canceled
|
—
|
|
|
—
|
|
|
|
|
|
|||
Expired
|
—
|
|
|
—
|
|
|
|
|
|
|||
March 31, 2020
|
81,667
|
|
|
$
|
99.00
|
|
|
7.9
|
|
$
|
—
|
|
|
Three Months Ended
|
|
||||||
|
March 31,
|
|
||||||
(Amounts in thousands, except per share data)
|
2020
|
|
2019
|
|
||||
Net income/(loss) from continuing operations applicable to Piper Sandler Companies
|
$
|
(14,727
|
)
|
|
$
|
19,561
|
|
|
Net loss from discontinued operations
|
—
|
|
|
(139
|
)
|
|
||
Net income/(loss) applicable to Piper Sandler Companies
|
(14,727
|
)
|
|
19,422
|
|
|
||
Earnings allocated to participating securities
|
—
|
|
|
(1,587
|
)
|
(1)
|
||
Net income/(loss) applicable to Piper Sandler Companies' common shareholders
|
$
|
(14,727
|
)
|
|
$
|
17,835
|
|
(2)
|
|
|
|
|
|
||||
Shares for basic and diluted calculations:
|
|
|
|
|
||||
Average shares used in basic computation
|
13,796
|
|
|
13,204
|
|
|
||
Restricted stock units
|
106
|
|
|
205
|
|
|
||
Non-participating restricted shares
|
509
|
|
|
121
|
|
|
||
Average shares used in diluted computation (3)
|
14,411
|
|
|
13,530
|
|
|
||
|
|
|
|
|
||||
Earnings/(loss) per basic common share:
|
|
|
|
|
||||
Income/(loss) from continuing operations
|
$
|
(1.07
|
)
|
|
$
|
1.36
|
|
|
Loss from discontinued operations
|
—
|
|
|
(0.01
|
)
|
|
||
Earnings/(loss) per basic common share
|
$
|
(1.07
|
)
|
|
$
|
1.35
|
|
|
|
|
|
|
|
||||
Earnings/(loss) per diluted common share:
|
|
|
|
|
||||
Income/(loss) from continuing operations
|
$
|
(1.07
|
)
|
|
$
|
1.33
|
|
|
Loss from discontinued operations
|
—
|
|
|
(0.01
|
)
|
|
||
Earnings/(loss) per diluted common share (3)
|
$
|
(1.07
|
)
|
|
$
|
1.32
|
|
|
(1)
|
Represents the allocation of distributed and undistributed earnings to participating securities. No allocation of undistributed earnings is made for periods in which a loss is incurred, or for periods in which cash dividends exceed net income resulting in an undistributed loss. Distributed earnings (e.g., dividends) are allocated to participating securities. Participating securities include the Company's unvested restricted shares issued prior to the 2019 Annual Grant. The weighted average participating shares outstanding were 1,130,844 for the three months ended March 31, 2019.
|
(2)
|
Net income/(loss) applicable to Piper Sandler Companies' common shareholders for diluted and basic EPS may differ under the two-class method as a result of adding the effect of the assumed exercise of stock options, restricted stock units and non-participating restricted shares to dilutive shares outstanding, which alters the ratio used to allocate earnings to Piper Sandler Companies' common shareholders and participating securities for purposes of calculating diluted and basic EPS.
|
(3)
|
Earnings per diluted common share is calculated using the basic weighted average number of common shares outstanding for periods in which a loss is incurred, or for periods prior to 2020 in which cash dividends exceed net income resulting in an undistributed loss. Common shares of 533,207 were excluded from diluted EPS for the three months ended March 31, 2019, as the Company had an undistributed loss for this period under the two class method.
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Investment banking
|
|
|
|
||||
Advisory services
|
$
|
111,226
|
|
|
$
|
114,879
|
|
Corporate financing
|
25,176
|
|
|
13,516
|
|
||
Municipal financing
|
22,596
|
|
|
12,666
|
|
||
Total investment banking
|
158,998
|
|
|
141,061
|
|
||
|
|
|
|
||||
Institutional brokerage
|
|
|
|
||||
Equity brokerage
|
47,853
|
|
|
15,906
|
|
||
Fixed income services
|
41,290
|
|
|
19,059
|
|
||
Total institutional brokerage
|
89,143
|
|
|
34,965
|
|
||
|
|
|
|
||||
Interest income
|
6,065
|
|
|
7,567
|
|
||
Investment income/(loss)
|
(13,826
|
)
|
|
1,592
|
|
||
|
|
|
|
||||
Total revenues
|
240,380
|
|
|
185,185
|
|
||
|
|
|
|
||||
Interest expense
|
4,212
|
|
|
2,643
|
|
||
|
|
|
|
||||
Net revenues
|
236,168
|
|
|
182,542
|
|
||
|
|
|
|
||||
Non-interest expenses (1)
|
270,197
|
|
|
159,405
|
|
||
|
|
|
|
||||
Pre-tax income/(loss)
|
$
|
(34,029
|
)
|
|
$
|
23,137
|
|
|
|
|
|
||||
Pre-tax margin
|
(14.4
|
)%
|
|
12.7
|
%
|
(1)
|
Non-interest expenses include intangible asset amortization of $9.9 million and $0.8 million for the three months ended March 31, 2020 and 2019, respectively.
|
ITEM 2.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
•
|
On January 3, 2020, we completed the acquisition of Sandler O'Neill, a full-service investment banking firm and broker dealer focused on the financial services industry. The acquisition of Sandler O'Neill is accretive to our advisory services revenues, diversifies and enhances scale in corporate financings, adds a differentiated fixed income services business, and increases scale in our equity brokerage business.
|
•
|
On August 2, 2019, we completed the acquisition of Weeden & Co. L.P. ("Weeden & Co."). Weeden & Co. is a broker dealer focused on providing institutional clients with global trading solutions, specializing in best execution through the use of high-touch, low-touch and program trading capabilities. The transaction added enhanced trade execution capabilities and scale to our equity brokerage business.
|
•
|
On April 3, 2020, we completed the acquisition of The Valence Group, an investment bank offering mergers and acquisitions advisory services to companies and financial sponsors with a focus on the chemicals, materials and related sectors. The transaction adds a new industry sector and expands our presence in Europe.
|
|
|
Three Months Ended
|
|||||||||
(Amounts in thousands, except per share data)
|
|
Mar. 31,
|
|
Mar. 31,
|
|
2020
|
|||||
|
2020
|
|
2019
|
|
v2019
|
||||||
U.S. GAAP
|
|
|
|
|
|
|
|||||
Net revenues
|
|
$
|
236,168
|
|
|
$
|
182,542
|
|
|
29.4
|
%
|
Compensation and benefits
|
|
188,124
|
|
|
117,127
|
|
|
60.6
|
|
||
Non-compensation expenses
|
|
82,073
|
|
|
42,278
|
|
|
94.1
|
|
||
Net income/(loss) applicable to Piper Sandler Companies
|
|
(14,727
|
)
|
|
19,422
|
|
|
N/M
|
|
||
Earnings/(loss) per diluted common share
|
|
$
|
(1.07
|
)
|
|
$
|
1.32
|
|
|
N/M
|
|
|
|
|
|
|
|
|
|||||
Non-GAAP(1)
|
|
|
|
|
|
|
|||||
Adjusted net revenues
|
|
$
|
244,922
|
|
|
$
|
182,129
|
|
|
34.5
|
%
|
Adjusted compensation and benefits
|
|
158,693
|
|
|
114,820
|
|
|
38.2
|
|
||
Adjusted non-compensation expenses
|
|
57,216
|
|
|
40,382
|
|
|
41.7
|
|
||
Adjusted net income applicable to Piper Sandler Companies
|
|
25,424
|
|
|
22,187
|
|
|
14.6
|
|
||
Adjusted earnings per diluted common share
|
|
$
|
1.48
|
|
|
$
|
1.51
|
|
|
(2.0
|
)
|
•
|
Net revenues were up 29.4 percent from the year-ago period reflecting the investments we have made in our business through the acquisitions of Sandler O'Neill in the first quarter of 2020 and Weeden & Co. in the third quarter of 2019. In the first quarter of 2020, higher institutional brokerage, corporate financing and municipal financing revenues were partially offset by lower advisory services revenues and an investment loss. Our institutional brokerage revenues were driven by robust activity in an extremely volatile market.
|
•
|
Compensation and benefits expenses increased 60.6 percent compared with the prior-year period due to additional headcount resulting from our acquisitions of Sandler O'Neill and Weeden & Co., as well as higher acquisition-related costs related to restricted consideration and retention awards associated with these acquisitions. We also recorded additional compensation expense for an earnout associated with the Weeden & Co. acquisition related to our expectations of achieving a net revenue target, as our equity brokerage business is outperforming initial projections.
|
•
|
Non-compensation expenses were up 94.1 percent compared to the year-ago period driven by the addition of Sandler O'Neill and Weeden & Co. to our platform. We also recorded higher acquisition-related non-compensation costs due to a $12.1 million fair value adjustment to the Weeden & Co. earnout related to non-employee equity owners. We recorded the full value of the projected earnout for these non-employees as they do not have service requirements.
|
•
|
In the first quarter of 2020, we recorded $5.7 million of income tax benefits primarily related to new tax provisions in the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"), which was enacted by the U.S. federal government on March 27, 2020 in response to the COVID-19 pandemic. The CARES Act contains tax provisions allowing a five-year carry back of any net operating losses incurred during federal tax years 2018, 2019 and 2020, to periods when the corporate federal tax rate was 35 percent. The impact of these new tax provisions on earnings per diluted common share was $0.41 in the first quarter of 2020.
|
•
|
For the three months ended March 31, 2020 and 2019, we recorded a tax benefit of $0.2 million and $1.7 million, respectively, related to restricted stock vesting at values greater than the grant price. The impact of the tax benefit on earnings per diluted common share was $0.13 in the first quarter of 2019.
|
(1)
|
Reconciliation of U.S. GAAP to adjusted non-GAAP financial information
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in thousands, except per share data)
|
2020
|
|
2019
|
||||
Net revenues:
|
|
|
|
||||
Net revenues – U.S. GAAP basis
|
$
|
236,168
|
|
|
$
|
182,542
|
|
Adjustments:
|
|
|
|
||||
Revenue related to noncontrolling interests
|
6,536
|
|
|
(413
|
)
|
||
Interest expense on senior notes
|
2,218
|
|
|
—
|
|
||
Adjusted net revenues
|
$
|
244,922
|
|
|
$
|
182,129
|
|
|
|
|
|
||||
Compensation and benefits:
|
|
|
|
||||
Compensation and benefits – U.S. GAAP basis
|
$
|
188,124
|
|
|
$
|
117,127
|
|
Adjustments:
|
|
|
|
||||
Compensation from acquisition-related agreements
|
(29,431
|
)
|
|
(2,307
|
)
|
||
Adjusted compensation and benefits
|
$
|
158,693
|
|
|
$
|
114,820
|
|
|
|
|
|
||||
Non-compensation expenses:
|
|
|
|
||||
Non-compensation expenses – U.S. GAAP basis
|
$
|
82,073
|
|
|
$
|
42,278
|
|
Adjustments:
|
|
|
|
||||
Non-compensation expenses related to noncontrolling interests
|
(992
|
)
|
|
(1,029
|
)
|
||
Acquisition-related restructuring and integration costs
|
(1,902
|
)
|
|
—
|
|
||
Amortization of intangible assets related to acquisitions
|
(9,878
|
)
|
|
(753
|
)
|
||
Non-compensation expenses from acquisition-related agreements
|
(12,085
|
)
|
|
(114
|
)
|
||
Adjusted non-compensation expenses
|
$
|
57,216
|
|
|
$
|
40,382
|
|
|
|
|
|
||||
Net income/(loss) applicable to Piper Sandler Companies:
|
|
|
|
||||
Net income/(loss) applicable to Piper Sandler Companies – U.S. GAAP basis
|
$
|
(14,727
|
)
|
|
$
|
19,422
|
|
Adjustment to exclude net loss from discontinued operations
|
—
|
|
|
(139
|
)
|
||
Net income/(loss) from continuing operations
|
$
|
(14,727
|
)
|
|
$
|
19,561
|
|
Adjustments:
|
|
|
|
||||
Compensation from acquisition-related agreements
|
22,343
|
|
|
1,941
|
|
||
Acquisition-related restructuring and integration costs
|
1,419
|
|
|
—
|
|
||
Amortization of intangible assets related to acquisitions
|
7,373
|
|
|
571
|
|
||
Non-compensation expenses from acquisition-related agreements
|
9,016
|
|
|
114
|
|
||
Adjusted net income applicable to Piper Sandler Companies
|
$
|
25,424
|
|
|
$
|
22,187
|
|
|
|
|
|
||||
Earnings/(loss) per diluted common share:
|
|
|
|
||||
Earnings/(loss) per diluted common share – U.S. GAAP basis
|
$
|
(1.07
|
)
|
|
$
|
1.32
|
|
Adjustment to exclude net loss from discontinued operations
|
—
|
|
|
(0.01
|
)
|
||
Income/(loss) from continuing operations
|
$
|
(1.07
|
)
|
|
$
|
1.33
|
|
Impact of antidilutive shares in a period of a loss
|
0.05
|
|
|
—
|
|
||
Adjustment for inclusion of unvested acquisition-related stock
|
(0.28
|
)
|
|
—
|
|
||
|
$
|
(1.30
|
)
|
|
$
|
1.33
|
|
Adjustments:
|
|
|
|
||||
Compensation from acquisition-related agreements
|
1.55
|
|
|
0.13
|
|
||
Acquisition-related restructuring and integration costs
|
0.10
|
|
|
—
|
|
||
Amortization of intangible assets related to acquisitions
|
0.51
|
|
|
0.04
|
|
||
Non-compensation expenses from acquisition-related agreements
|
0.62
|
|
|
0.01
|
|
||
Adjusted earnings per diluted common share
|
$
|
1.48
|
|
|
$
|
1.51
|
|
|
|
|
|
||||
Weighted average diluted common shares outstanding:
|
|
|
|
||||
Weighted average diluted common shares outstanding – U.S. GAAP basis
|
14,411
|
|
|
13,530
|
|
||
Adjustment:
|
|
|
|
||||
Unvested acquisition-related restricted stock with service conditions
|
2,748
|
|
|
—
|
|
||
Adjusted weighted average diluted common shares outstanding
|
17,159
|
|
|
13,530
|
|
|
|
|
|
|
|
|
As a Percentage of
|
|||||||||
|
|
|
|
|
|
|
Net Revenues for the
|
|||||||||
|
Three Months Ended
|
|
Three Months Ended
|
|||||||||||||
|
March 31,
|
|
March 31,
|
|||||||||||||
|
|
|
|
|
2020
|
|
|
|
|
|||||||
(Amounts in thousands)
|
2020
|
|
2019
|
|
v2019
|
|
2020
|
|
2019
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|
|
|||||||
Investment banking
|
$
|
158,998
|
|
|
$
|
141,061
|
|
|
12.7
|
%
|
|
67.3
|
%
|
|
77.3
|
%
|
Institutional brokerage
|
89,143
|
|
|
34,965
|
|
|
154.9
|
|
|
37.7
|
|
|
19.2
|
|
||
Interest income
|
6,065
|
|
|
7,567
|
|
|
(19.8
|
)
|
|
2.6
|
|
|
4.1
|
|
||
Investment income/(loss)
|
(13,826
|
)
|
|
1,592
|
|
|
N/M
|
|
|
(5.9
|
)
|
|
0.9
|
|
||
Total revenues
|
240,380
|
|
|
185,185
|
|
|
29.8
|
|
|
101.8
|
|
|
101.4
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Interest expense
|
4,212
|
|
|
2,643
|
|
|
59.4
|
|
|
1.8
|
|
|
1.4
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Net revenues
|
236,168
|
|
|
182,542
|
|
|
29.4
|
|
|
100.0
|
|
|
100.0
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Non-interest expenses:
|
|
|
|
|
|
|
|
|
|
|||||||
Compensation and benefits
|
188,124
|
|
|
117,127
|
|
|
60.6
|
|
|
79.7
|
|
|
64.2
|
|
||
Outside services
|
8,439
|
|
|
8,571
|
|
|
(1.5
|
)
|
|
3.6
|
|
|
4.7
|
|
||
Occupancy and equipment
|
12,238
|
|
|
8,349
|
|
|
46.6
|
|
|
5.2
|
|
|
4.6
|
|
||
Communications
|
11,634
|
|
|
7,865
|
|
|
47.9
|
|
|
4.9
|
|
|
4.3
|
|
||
Marketing and business development
|
10,039
|
|
|
6,738
|
|
|
49.0
|
|
|
4.3
|
|
|
3.7
|
|
||
Deal-related expenses
|
4,940
|
|
|
4,728
|
|
|
4.5
|
|
|
2.1
|
|
|
2.6
|
|
||
Trade execution and clearance
|
7,151
|
|
|
1,806
|
|
|
296.0
|
|
|
3.0
|
|
|
1.0
|
|
||
Restructuring and integration costs
|
1,902
|
|
|
—
|
|
|
N/M
|
|
|
0.8
|
|
|
—
|
|
||
Intangible asset amortization
|
9,878
|
|
|
753
|
|
|
N/M
|
|
|
4.2
|
|
|
0.4
|
|
||
Other operating expenses
|
15,852
|
|
|
3,468
|
|
|
357.1
|
|
|
6.7
|
|
|
1.9
|
|
||
Total non-interest expenses
|
270,197
|
|
|
159,405
|
|
|
69.5
|
|
|
114.4
|
|
|
87.3
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Income/(loss) from continuing operations before income tax expense/(benefit)
|
(34,029
|
)
|
|
23,137
|
|
|
N/M
|
|
|
(14.4
|
)
|
|
12.7
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Income tax expense/(benefit)
|
(11,774
|
)
|
|
4,192
|
|
|
N/M
|
|
|
(5.0
|
)
|
|
2.3
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Income/(loss) from continuing operations
|
(22,255
|
)
|
|
18,945
|
|
|
N/M
|
|
|
(9.4
|
)
|
|
10.4
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Discontinued operations:
|
|
|
|
|
|
|
|
|
|
|||||||
Loss from discontinued operations, net of tax
|
—
|
|
|
(139
|
)
|
|
N/M
|
|
|
—
|
|
|
(0.1
|
)
|
||
Net income/(loss)
|
(22,255
|
)
|
|
18,806
|
|
|
N/M
|
|
|
(9.4
|
)
|
|
10.3
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Net loss applicable to noncontrolling interests
|
(7,528
|
)
|
|
(616
|
)
|
|
N/M
|
|
|
(3.2
|
)
|
|
(0.3
|
)
|
||
|
|
|
|
|
|
|
|
|
|
|||||||
Net income/(loss) applicable to Piper Sandler Companies
|
$
|
(14,727
|
)
|
|
$
|
19,422
|
|
|
N/M
|
|
|
(6.2
|
)%
|
|
10.6
|
%
|
|
Three Months Ended March 31,
|
||||||||||||||||||||||||||||||
|
2020
|
|
2019
|
||||||||||||||||||||||||||||
|
|
|
Adjustments (1)
|
|
|
|
|
|
Adjustments (1)
|
|
|
||||||||||||||||||||
|
Total
|
|
Noncontrolling
|
|
Other
|
|
U.S.
|
|
Total
|
|
Noncontrolling
|
|
Other
|
|
U.S.
|
||||||||||||||||
(Amounts in thousands)
|
Adjusted
|
|
Interests
|
|
Adjustments
|
|
GAAP
|
|
Adjusted
|
|
Interests
|
|
Adjustments
|
|
GAAP
|
||||||||||||||||
Investment banking
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Advisory services
|
$
|
111,226
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
111,226
|
|
|
$
|
114,879
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
114,879
|
|
Corporate financing
|
25,176
|
|
|
—
|
|
|
—
|
|
|
25,176
|
|
|
13,516
|
|
|
—
|
|
|
—
|
|
|
13,516
|
|
||||||||
Municipal financing
|
22,596
|
|
|
—
|
|
|
—
|
|
|
22,596
|
|
|
12,666
|
|
|
—
|
|
|
—
|
|
|
12,666
|
|
||||||||
Total investment banking
|
158,998
|
|
|
—
|
|
|
—
|
|
|
158,998
|
|
|
141,061
|
|
|
—
|
|
|
—
|
|
|
141,061
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Institutional brokerage
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Equity brokerage
|
47,853
|
|
|
—
|
|
|
—
|
|
|
47,853
|
|
|
15,906
|
|
|
—
|
|
|
—
|
|
|
15,906
|
|
||||||||
Fixed income services
|
41,290
|
|
|
—
|
|
|
—
|
|
|
41,290
|
|
|
19,059
|
|
|
—
|
|
|
—
|
|
|
19,059
|
|
||||||||
Total institutional brokerage
|
89,143
|
|
|
—
|
|
|
—
|
|
|
89,143
|
|
|
34,965
|
|
|
—
|
|
|
—
|
|
|
34,965
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest income
|
6,065
|
|
|
—
|
|
|
—
|
|
|
6,065
|
|
|
7,567
|
|
|
—
|
|
|
—
|
|
|
7,567
|
|
||||||||
Investment income/(loss)
|
(7,290
|
)
|
|
(6,536
|
)
|
|
—
|
|
|
(13,826
|
)
|
|
1,179
|
|
|
413
|
|
|
—
|
|
|
1,592
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Total revenues
|
246,916
|
|
|
(6,536
|
)
|
|
—
|
|
|
240,380
|
|
|
184,772
|
|
|
413
|
|
|
—
|
|
|
185,185
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest expense
|
1,994
|
|
|
—
|
|
|
2,218
|
|
|
4,212
|
|
|
2,643
|
|
|
—
|
|
|
—
|
|
|
2,643
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Net revenues
|
244,922
|
|
|
(6,536
|
)
|
|
(2,218
|
)
|
|
236,168
|
|
|
182,129
|
|
|
413
|
|
|
—
|
|
|
182,542
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Non-interest expenses
|
215,909
|
|
|
992
|
|
|
53,296
|
|
|
270,197
|
|
|
155,202
|
|
|
1,029
|
|
|
3,174
|
|
|
159,405
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Pre-tax income/(loss)
|
$
|
29,013
|
|
|
$
|
(7,528
|
)
|
|
$
|
(55,514
|
)
|
|
$
|
(34,029
|
)
|
|
$
|
26,927
|
|
|
$
|
(616
|
)
|
|
$
|
(3,174
|
)
|
|
$
|
23,137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Pre-tax margin
|
11.8
|
%
|
|
|
|
|
|
(14.4
|
)%
|
|
14.8
|
%
|
|
|
|
|
|
12.7
|
%
|
(1)
|
The following is a summary of the adjustments needed to reconcile our consolidated U.S. GAAP financial results to the adjusted financial results:
|
|
Three Months Ended March 31,
|
||||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Compensation from acquisition-related agreements
|
$
|
29,431
|
|
|
$
|
2,307
|
|
Acquisition-related restructuring and integration costs
|
1,902
|
|
|
—
|
|
||
Amortization of intangible assets related to acquisitions
|
9,878
|
|
|
753
|
|
||
Non-compensation expenses from acquisition-related agreements
|
12,085
|
|
|
114
|
|
||
|
$
|
53,296
|
|
|
$
|
3,174
|
|
•
|
Valuation of Financial Instruments
|
•
|
Goodwill and Intangible Assets
|
•
|
Compensation Plans
|
•
|
Income Taxes
|
Declaration Date
|
|
Dividend Per Share
|
|
|
Record Date
|
|
Payment Date
|
|
February 1, 2019 (1)
|
|
$
|
1.010
|
|
|
February 25, 2019
|
|
March 15, 2019
|
February 1, 2019
|
|
$
|
0.375
|
|
|
February 25, 2019
|
|
March 15, 2019
|
April 26, 2019
|
|
$
|
0.375
|
|
|
May 24, 2019
|
|
June 14, 2019
|
July 26, 2019
|
|
$
|
0.375
|
|
|
August 23, 2019
|
|
September 13, 2019
|
October 30, 2019
|
|
$
|
0.375
|
|
|
November 22, 2019
|
|
December 13, 2019
|
January 31, 2020 (2)
|
|
$
|
0.750
|
|
|
March 2, 2020
|
|
March 13, 2020
|
January 31, 2020
|
|
$
|
0.375
|
|
|
March 2, 2020
|
|
March 13, 2020
|
May 1, 2020
|
|
$
|
0.200
|
|
|
May 29, 2020
|
|
June 12, 2020
|
(1)
|
Represents the annual special cash dividend based on our fiscal year 2018 results.
|
(2)
|
Represents the annual special cash dividend based on our fiscal year 2019 results.
|
|
March 31,
|
|
December 31,
|
||||
(Dollars in thousands)
|
2020
|
|
2019
|
||||
Total assets
|
$
|
1,517,880
|
|
|
$
|
1,628,719
|
|
Deduct: Goodwill and intangible assets
|
(346,216
|
)
|
|
(104,335
|
)
|
||
Deduct: Right-of-use lease asset
|
(74,847
|
)
|
|
(40,030
|
)
|
||
Deduct: Assets from noncontrolling interests
|
(67,310
|
)
|
|
(76,516
|
)
|
||
Adjusted assets
|
$
|
1,029,507
|
|
|
$
|
1,407,838
|
|
|
|
|
|
||||
Total shareholders' equity
|
$
|
796,075
|
|
|
$
|
806,528
|
|
Deduct: Goodwill and intangible assets
|
(346,216
|
)
|
|
(104,335
|
)
|
||
Deduct: Noncontrolling interests
|
(66,516
|
)
|
|
(75,245
|
)
|
||
Tangible common shareholders' equity
|
$
|
383,343
|
|
|
$
|
626,948
|
|
|
|
|
|
||||
Leverage ratio (1)
|
1.9
|
|
|
2.0
|
|
||
|
|
|
|
||||
Adjusted leverage ratio (2)
|
2.7
|
|
|
2.2
|
|
(1)
|
Leverage ratio equals total assets divided by total shareholders' equity.
|
(2)
|
Adjusted leverage ratio equals adjusted assets divided by tangible common shareholders' equity.
|
(Dollars in millions)
|
CP Series II A
|
||
Maximum amount that may be issued
|
$
|
200.0
|
|
Amount outstanding
|
50.0
|
|
|
|
|
||
Weighted average maturity, in days
|
6
|
|
|
Weighted average maturity at issuance, in days
|
32
|
|
|
|
Average Balance for the Three Months Ended
|
||||||||||||||||||
(Amounts in millions)
|
|
Mar. 31, 2020
|
|
Dec. 31, 2019
|
|
Sept. 30, 2019
|
|
June 30, 2019
|
|
Mar. 31, 2019
|
||||||||||
Funding source:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Pershing clearing arrangement
|
|
$
|
117.8
|
|
|
$
|
22.9
|
|
|
$
|
94.6
|
|
|
$
|
170.2
|
|
|
$
|
82.1
|
|
Commercial paper
|
|
50.0
|
|
|
50.0
|
|
|
50.0
|
|
|
50.0
|
|
|
50.0
|
|
|||||
Prime broker arrangement
|
|
72.3
|
|
|
99.7
|
|
|
68.0
|
|
|
77.1
|
|
|
106.4
|
|
|||||
Revolving credit facility
|
|
7.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
|
$
|
247.2
|
|
|
$
|
172.6
|
|
|
$
|
212.6
|
|
|
$
|
297.3
|
|
|
$
|
238.5
|
|
(Amounts in millions)
|
|
2020
|
|
2019
|
||||
First Quarter
|
|
$
|
642.1
|
|
|
$
|
362.7
|
|
Second Quarter
|
|
|
|
$
|
427.1
|
|
||
Third Quarter
|
|
|
|
$
|
416.0
|
|
||
Fourth Quarter
|
|
|
|
$
|
330.7
|
|
|
Remainder of 2020
|
|
2021
|
|
2023
|
|
2025 and
|
|
|
||||||||||
(Amounts in millions)
|
|
- 2022
|
|
- 2024
|
|
thereafter
|
|
Total
|
|||||||||||
Operating lease obligations
|
$
|
17.7
|
|
|
$
|
36.1
|
|
|
$
|
26.4
|
|
|
$
|
25.7
|
|
|
$
|
105.9
|
|
Purchase commitments
|
19.0
|
|
|
23.0
|
|
|
7.6
|
|
|
8.8
|
|
|
58.4
|
|
|
Expiration Per Period at December 31,
|
|
Total Contractual Amount
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
2023
|
|
2025
|
|
|
|
March 31,
|
|
December 31,
|
||||||||||||||||
(Amounts in thousands)
|
2020
|
|
2021
|
|
2022
|
|
- 2024
|
|
- 2026
|
|
Later
|
|
2020
|
|
2019
|
||||||||||||||||
Customer matched-book derivative contracts (1) (2)
|
$
|
19,040
|
|
|
$
|
6,930
|
|
|
$
|
24,150
|
|
|
$
|
141,370
|
|
|
$
|
15,160
|
|
|
$
|
1,816,741
|
|
|
$
|
2,023,391
|
|
|
$
|
2,197,340
|
|
Trading securities derivative contracts (2)
|
187,700
|
|
|
12,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,375
|
|
|
209,075
|
|
|
110,875
|
|
||||||||
Equity option derivative contracts (2)
|
13,703
|
|
|
2,515
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,218
|
|
|
—
|
|
||||||||
Investment commitments (3)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
70,861
|
|
|
70,953
|
|
(1)
|
Consists of interest rate swaps. We have minimal market risk related to these matched-book derivative contracts; however, we do have counterparty risk with one major financial institution, which is mitigated by collateral deposits. In addition, we have a limited number of counterparties (contractual amount of $173.0 million at March 31, 2020) who are not required to post collateral. The uncollateralized amounts, representing the fair value of the derivative contracts, expose us to the credit risk of these counterparties. At March 31, 2020, we had $27.3 million of credit exposure with these counterparties, including $23.2 million of credit exposure with one counterparty.
|
(2)
|
We believe the fair value of these derivative contracts is a more relevant measure of the obligations because we believe the notional or contract amount overstates the expected payout. At March 31, 2020 and December 31, 2019, the net fair value of these derivative contracts approximated $24.8 million and $16.3 million, respectively.
|
(3)
|
The investment commitments have no specified call dates. The timing of capital calls is based on market conditions and investment opportunities.
|
|
March 31,
|
|
December 31,
|
||||
(Amounts in thousands)
|
2020
|
|
2019
|
||||
Interest Rate Risk
|
$
|
494
|
|
|
$
|
428
|
|
Equity Price Risk
|
47
|
|
|
52
|
|
||
Diversification Effect (1)
|
(27
|
)
|
|
(37
|
)
|
||
Total Value-at-Risk
|
$
|
514
|
|
|
$
|
443
|
|
(1)
|
Equals the difference between total VaR and the sum of the VaRs for the two risk categories. This effect arises because the two market risk categories are not perfectly correlated.
|
(Amounts in thousands)
|
High
|
|
Low
|
|
Average
|
||||||
For the Three Months Ended March 31, 2020
|
|
|
|
|
|
||||||
Interest Rate Risk
|
$
|
918
|
|
|
$
|
433
|
|
|
$
|
652
|
|
Equity Price Risk
|
63
|
|
|
44
|
|
|
53
|
|
|||
Diversification Effect (1)
|
|
|
|
|
(30
|
)
|
|||||
Total Value-at-Risk
|
$
|
943
|
|
|
$
|
455
|
|
|
$
|
675
|
|
(Amounts in thousands)
|
High
|
|
Low
|
|
Average
|
||||||
For the Year Ended December 31, 2019
|
|
|
|
|
|
||||||
Interest Rate Risk
|
$
|
792
|
|
|
$
|
181
|
|
|
$
|
432
|
|
Equity Price Risk
|
69
|
|
|
42
|
|
|
54
|
|
|||
Diversification Effect (1)
|
|
|
|
|
(41
|
)
|
|||||
Total Value-at-Risk
|
$
|
808
|
|
|
$
|
191
|
|
|
$
|
445
|
|
(1)
|
Equals the difference between total VaR and the sum of the VaRs for the two risk categories. This effect arises because the two market risk categories are not perfectly correlated. Because high and low VaR numbers for these risk categories may have occurred on different days, high and low numbers for diversification effect would not be meaningful.
|
(1)
|
Effective January 1, 2020, our board of directors authorized the repurchase of up to $150.0 million of common stock through December 31, 2021.
|
(2)
|
Consists of 44,973 shares of common stock repurchased on the open market pursuant to a 10b5-1 plan established with an independent agent at an average price of $72.45 per share, and 91,674 shares of common stock withheld from recipients of restricted stock to pay taxes upon the vesting of the restricted stock at an average price of $85.38 per share.
|
Exhibit Index
|
||||
Exhibit
|
|
|
|
Method
|
Number
|
|
Description
|
|
of Filing
|
|
|
|
|
|
3.1
|
|
|
|
|
3.2
|
|
|
|
|
3.3
|
|
|
|
|
31.1
|
|
|
Filed herewith
|
|
31.2
|
|
|
Filed herewith
|
|
32.1
|
|
|
Filed herewith
|
|
101
|
|
The following financial information from our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Financial Condition, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Changes in Shareholders' Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to the Consolidated Financial Statements.
|
|
Filed herewith
|
104
|
|
The cover page from our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, formatted in iXBRL.
|
|
Filed herewith
|
|
|
|
PIPER SANDLER COMPANIES
|
||
|
|
|
|
|
|
Date:
|
May 8, 2020
|
|
By
|
|
/s/ Chad R. Abraham
|
|
|
|
Name
|
|
Chad R. Abraham
|
|
|
|
Its
|
|
Chairman and Chief Executive Officer
|
|
|
|
|
|
|
Date:
|
May 8, 2020
|
|
By
|
|
/s/ Timothy L. Carter
|
|
|
|
Name
|
|
Timothy L. Carter
|
|
|
|
Its
|
|
Chief Financial Officer
|
1 Year Piper Jaffray Companies Chart |
1 Month Piper Jaffray Companies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions